Advertisement

Author: Mukuntha Subburayan

Targeting CNS cells Key to Abrogate MS Progression

Prof. Tony Traboulsee talks to Physician’s Weekly about his study of tolebrutinib Presented at the American Academy of Neurology (AAN) 2021 Annual Meeting, Anthony Traboulsee, MD, professor and research chair of the MS Society...

Read More

2021 AAN Annual Meeting Kick-Off!

Due to the COVID-19 pandemic, the 2021 American Academy of Neurology Annual Meeting, the world’s premier neurology meeting, will be held in a fully virtual format from April 17-22. It will include: Over 90 expert-led CME...

Read More

AAN 2021: Dual Tasking In Patients With MS

Patients with MS may have difficulty performing double task (DT) while walking or causing interference. More research is needed in order to define the role of disability degree in the severity of the interference produced in the...

Read More

Maybe We’re Not All Hanging in There. And That’s OK

A s a palliative care doctor in NYC during the beginning of the pandemic, my typical greeting response of “I’m fine” was speedily replaced with “I’m hanging in there.” It seemed slightly less false (because who’s really “fine”...

Read More

Pediatric-Onset MS and Social Consequences

Pediatric-onset MS (PoMS) is associated with less educational achievement, lower earnings, and greater use of disability benefits throughout the working-age life span, according to a study published in JAMA Neurology....

Read More

For latest news and updates
Email-id is invalid